Elanco, Eli Lilly report strong Q2 results, raise guidance
Elanco Animal Health reported better-than-expected second-quarter results and raised FY26 guidance above estimates, while Eli Lilly also reported better-than-expected second-quarter results and raised FY26 sales guidance, with the midpoint above estimates.